1. Home
  2. NRXP vs CSTE Comparison

NRXP vs CSTE Comparison

Compare NRXP & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CSTE
  • Stock Information
  • Founded
  • NRXP 2015
  • CSTE 1987
  • Country
  • NRXP United States
  • CSTE Israel
  • Employees
  • NRXP N/A
  • CSTE N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CSTE Building Materials
  • Sector
  • NRXP Health Care
  • CSTE Industrials
  • Exchange
  • NRXP Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • NRXP 73.7M
  • CSTE 61.9M
  • IPO Year
  • NRXP N/A
  • CSTE 2012
  • Fundamental
  • Price
  • NRXP $2.14
  • CSTE $0.95
  • Analyst Decision
  • NRXP Strong Buy
  • CSTE
  • Analyst Count
  • NRXP 5
  • CSTE 0
  • Target Price
  • NRXP $31.60
  • CSTE N/A
  • AVG Volume (30 Days)
  • NRXP 480.7K
  • CSTE 221.5K
  • Earning Date
  • NRXP 11-17-2025
  • CSTE 11-12-2025
  • Dividend Yield
  • NRXP N/A
  • CSTE N/A
  • EPS Growth
  • NRXP N/A
  • CSTE N/A
  • EPS
  • NRXP N/A
  • CSTE N/A
  • Revenue
  • NRXP $242,000.00
  • CSTE $400,656,000.00
  • Revenue This Year
  • NRXP N/A
  • CSTE N/A
  • Revenue Next Year
  • NRXP $395.09
  • CSTE $5.61
  • P/E Ratio
  • NRXP N/A
  • CSTE N/A
  • Revenue Growth
  • NRXP N/A
  • CSTE N/A
  • 52 Week Low
  • NRXP $1.13
  • CSTE $0.92
  • 52 Week High
  • NRXP $6.01
  • CSTE $5.04
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 31.88
  • CSTE 26.87
  • Support Level
  • NRXP $2.04
  • CSTE $0.97
  • Resistance Level
  • NRXP $2.81
  • CSTE $1.02
  • Average True Range (ATR)
  • NRXP 0.22
  • CSTE 0.09
  • MACD
  • NRXP -0.06
  • CSTE 0.00
  • Stochastic Oscillator
  • NRXP 7.41
  • CSTE 7.41

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: